These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37119244)

  • 1. Evaluation of quantitative point-of-care test for measurement of glucose-6-phosphate dehydrogenase enzyme activity in Malaysia.
    Zailani MAH; Raja Sabudin RZA; Abdul Jalil D; Ithnin A; Ayub NA; Alauddin H; Jalil N; Md Fauzi A; Cheah FC; Lim LS; Safian N; Yusuf MM; Othman A
    Malays J Pathol; 2023 Apr; 45(1):31-41. PubMed ID: 37119244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
    Zobrist S; Brito M; Garbin E; Monteiro WM; Clementino Freitas S; Macedo M; Soares Moura A; Advani N; Kahn M; Pal S; Gerth-Guyette E; Bansil P; Domingo GJ; Pereira D; Lacerda MV
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009649. PubMed ID: 34383774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
    Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
    PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of quantitative biosensor for glucose-6-phosphate dehydrogenase activity detection.
    Pengboon P; Thamwarokun A; Changsri K; Kaset C; Chomean S
    PLoS One; 2019; 14(12):e0226927. PubMed ID: 31860695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.
    Brito MA; Peixoto HM; Almeida AC; Oliveira MR; Romero GA; Moura-Neto JP; Singh N; Monteiro WM; Lacerda MV
    Rev Soc Bras Med Trop; 2016; 49(4):446-55. PubMed ID: 27598631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
    Pal S; Bansil P; Bancone G; Hrutkay S; Kahn M; Gornsawun G; Penpitchaporn P; Chu CS; Nosten F; Domingo GJ
    Am J Trop Med Hyg; 2019 Jan; 100(1):213-221. PubMed ID: 30350771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd), CareStart qualitative rapid diagnostic test performance, and genetic variants in two malaria-endemic areas in Sudan.
    Ali Albsheer MM; Lover AA; Eltom SB; Omereltinai L; Mohamed N; Muneer MS; Mohamad AO; Abdel Hamid MM
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009720. PubMed ID: 34699526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
    Brito-Sousa JD; Murta F; Vitor-Silva S; Sampaio VS; Mendes MO; Brito MAM; Batista TSB; Santos APC; Marques LLG; Barbosa LRA; Melo MM; Baia-da-Silva DC; Silva-Neto AV; Santos TC; Souza BKA; Figueiredo EFG; Silva EL; Rodovalho S; Nakagawa TH; Arcanjo AR; Siqueira AM; Melo GC; Recht J; Domingo GJ; Bassat Q; Bancone G; Monteiro WM; Lacerda MVG
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009415. PubMed ID: 34003840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection.
    Abdul-Ghani R; Mahdy MA; Saif-Ali R; Alkubati SA; Alqubaty AR; Al-Mikhlafy AA; Al-Eryani SM; Al-Mekhlafi AM; Alhaj A
    Malar J; 2016 Jun; 15():327. PubMed ID: 27329471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
    Roca-Feltrer A; Khim N; Kim S; Chy S; Canier L; Kerleguer A; Tor P; Chuor CM; Kheng S; Siv S; Kachur PS; Taylor WR; Hwang J; Menard D
    PLoS One; 2014; 9(12):e116143. PubMed ID: 25541721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Evaluation of a New Quantitative Point-of Care Diagnostic to Measure Glucose-6-phosphate Dehydrogenase Activity.
    Bahk YY; Ahn SK; Jeon HJ; Na BK; Lee SK; Shin HJ
    Korean J Parasitol; 2022 Aug; 60(4):281-288. PubMed ID: 36041490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population screening for glucose-6-phosphate dehydrogenase deficiency using quantitative point-of-care tests: a systematic review.
    Zailani MAH; Raja Sabudin RZA; Ithnin A; Alauddin H; Sulaiman SA; Ismail E; Othman A
    Front Genet; 2023; 14():1098828. PubMed ID: 37388931
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania.
    Djigo OKM; Bollahi MA; Hasni Ebou M; Ould Ahmedou Salem MS; Tahar R; Bogreau H; Basco L; Ould Mohamed Salem Boukhary A
    PLoS One; 2019; 14(9):e0220977. PubMed ID: 31525211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
    Roh ME; Oyet C; Orikiriza P; Wade M; Mwanga-Amumpaire J; Boum Y; Kiwanuka GN; Parikh S
    Am J Trop Med Hyg; 2016 Nov; 95(5):1094-1099. PubMed ID: 27672207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical evaluation and usability of a quantitative G6PD POC test in cord blood: a mixed-methods study in a low-resource setting.
    Bancone G; Gilder ME; Win E; Gornsawun G; Penpitchaporn P; Moo PK; Archasuksan L; Wai NS; Win S; Aung KK; Hashmi A; Hanboonkunupakarn B; Nosten F; Carrara VI; McGready R
    BMJ Open; 2022 Dec; 12(12):e066529. PubMed ID: 36523222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania.
    Djigo OKM; Ould Khalef Y; Ould Ahmedou Salem MS; Gomez N; Basco L; Briolant S; Ould Mohamed Salem Boukhary A
    Infect Dis Poverty; 2021 Aug; 10(1):105. PubMed ID: 34353361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti.
    von Fricken ME; Weppelmann TA; Eaton WT; Masse R; Beau de Rochars MV; Okech BA
    Am J Trop Med Hyg; 2014 Jul; 91(1):77-80. PubMed ID: 24778197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia.
    Adhikari B; Tripura R; Dysoley L; Callery JJ; Peto TJ; Heng C; Vanda T; Simvieng O; Cassidy-Seyoum S; Ley B; Thriemer K; Dondorp AM; von Seidlein L
    Malar J; 2022 Oct; 21(1):282. PubMed ID: 36195916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
    Ley B; Winasti Satyagraha A; Rahmat H; von Fricken ME; Douglas NM; Pfeffer DA; Espino F; von Seidlein L; Henriques G; Oo NN; Menard D; Parikh S; Bancone G; Karahalios A; Price RN
    PLoS Med; 2019 Dec; 16(12):e1002992. PubMed ID: 31834890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenges of introducing routine G6PD testing into radical cure: a workshop report.
    Ley B; Luter N; Espino FE; Devine A; Kalnoky M; Lubell Y; Thriemer K; Baird JK; Poirot E; Conan N; Kheong CC; Dysoley L; Khan WA; Dion-Berboso AG; Bancone G; Hwang J; Kumar R; Price RN; von Seidlein L; Domingo GJ
    Malar J; 2015 Sep; 14():377. PubMed ID: 26416229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.